ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
Ashwin Rajeev, Aiswarya Sudheer and Indranil Chattopadhyay
Department of Biotechnology, Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, India.
Article Number: 8935 | © The Author(s). 2024
J Pure Appl Microbiol. 2024;18(1):80-99. https://doi.org/10.22207/JPAM.18.1.02
Received: 23 August 2023 | Accepted: 29 November 2023 | Published online: 19 January 2024
Issue online: March 2024
Abstract

In recent years, the scientific community has paid closer attention to the dynamics involved in metabolic and inflammatory diseases. Clinicians and researchers are confronting new challenges as a result of these rapidly spreading diseases with epidemic dimensions. A unique strategy that might shift the gut microbiota’s composition, improve food absorption, and modify the immune system in a way that would alleviate the disease was required to avert these dysbiotic conditions. The therapeutic effects of conventional probiotics were enhanced by the concurrent administration of prebiotics, synbiotics, and postbiotics. The sustainability characteristics of probiotic formulations lead to their use in a wide range of human health conditions, from digestive problems to cognitive impairment. Probiotics were created as a long-term approach to healthcare to increase individual well-being.

Keywords

Probiotics, Prebiotics, Synbiotics, Postbiotics, Psychobiotics, Probiogenomics

Article Metrics

Article View: 113

Share This Article

© The Author(s) 2024. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.